HEAE:LSE:LSE-SPDR® MSCI Europe Health Care UCITS ETF GBP (GBP)

ETF | Others |

Last Closing

USD 190.42

Change

+1.30 (+0.69)%

Market Cap

USD 0.64B

Volume

628.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.89 (-0.34%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

-0.01 (-0.01%)

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+26.00 (+0.31%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.74%)

USD 652.47B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.17 (+0.99%)

USD 650.46B
0R1I:LSE NVIDIA Corp.

-4.70 (-0.41%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+3.25 (+0.16%)

USD 330.91B

ETFs Containing HEAE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.90% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.90% 76% C+ 71% C-
Trailing 12 Months  
Capital Gain 6.47% 42% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.47% 40% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.93% 41% F 50% F
Dividend Return 1.93% 40% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.65% 91% A- 95% A
Risk Adjusted Return 52.83% 69% C- 80% B-
Market Capitalization 0.64B 74% C 63% D

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.